Trial Profile
A Phase 2, Randomized, Double-blind, Within-subject Controlled Study to Evaluate Efficacy and Safety of Various Doses and Regimens of EXC 001 for the Amelioration of Scarring Following Revision of Scars From Prior Breast Surgery in Adult Subjects (LEGACY EXCALIARD PROTOCOL # EXC 001-204)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2021
Price :
$35
*
At a glance
- Drugs PF 6473871 (Primary)
- Indications Scars
- Focus Therapeutic Use
- Sponsors Pfizer
- 09 May 2014 New trial record